TFS Capital’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
TFS Capital's TCON Position: Q1 2017 in Review
TFS Capital sold out of TRACON Pharmaceuticals (TCON) in Q1 2017, closing a stake of 84 shares — an estimated $82K sold.
TFS Capital first reported a position in TCON in Q3 2015 and held it in 3 quarters. The position peaked at $165K in Q3 2015. 22 funds tracked by Wall St. Rank hold TCON as of Q1 2017.
- TFS Capital reported no remaining TRACON Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
- TFS Capital sold 84 TRACON Pharmaceuticals shares in Q1 2017, an estimated $82K.
- TFS Capital first reported a position in TRACON Pharmaceuticals in Q3 2015 and held it in 3 quarters.
- TFS Capital's TRACON Pharmaceuticals position peaked at $165K in Q3 2015.
- 22 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q1 2017.
Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.